There's a myth that coffee should not be drunk because it can dehydrate your body and increase your risk of constipation. Is this true, however? The answer is no."People, who don't know much, think that if you are constipated for a long time, you might get colon cancer," said Professor Cha Jae-myung
VUNO, a Korean medical AI company, said Wednesday that it had completed the U.S. trademark registration of VUNO Med-DeepCARS, an artificial intelligence-based cardiac arrest prediction device.VUNO Med-DeepCARS is the first AI medical device in the Korean medical AI industry to be designated as an in
As part of the emergency medical care system to cope with doctors' collective action, the government will expand non-face-to-face medical treatment implemented by all types of medical institutions to public health centers and their branch offices.The government said so at Wednesday's regular briefin
Astellas Pharma Korea said it hosted the Satellite Symposium during the 2024 International Congress of the Korean Society of Hematology (ICKSH 2024) held at the Grand Walker Hill Seoul from March 28 to 30 to share the latest advances in the treatment of acute myeloid leukemia (AML).Professor Naoko H
In a troubling trend for the biotechnology sector in Korea, several companies are on the brink of delisting from the tech-heavy Kosdaq due to failing to secure necessary audit approvals amidst a harsh investment climate and lackluster sales and research outcomes.According to reports from the Korea E
Hahn & Co., a Korean private equity investment company, has completed the acquisition of Cynosure, a U.S. medical aesthetics company specializing in laser and light-based treatments, and is now taking steps to integrate Cynosure with Lutronic, a developer of advanced medical and aesthetic lasers and
To increase the options for hospice and life-sustaining treatment users, the government pushes to expand the target diseases and the timing to suspend end-of-life care that has been limited to patients’ dying days.The Ministry of Health and Welfare said Tuesday that it has finalized the "Second Comp
For people suffering from pollen-sensitive allergic rhinitis, springtime often proves to be a particularly challenging period, marked by incessant runny noses and bouts of sneezing. The problem is the persistence of these symptoms, which can last for weeks or even months. In such cases, nasal irriga
Senior doctors, who complained of "burnout" and vowed to work only 52 hours a week to prevent patient safety incidents due to striking junior doctors, have not been able to reduce their workload in reality.That’s because when they reduce their treatment by curtailing working hours, the hospital's “i
Vivozon Group, comprising Vivozon and Vivozon Pharmaceutical, has joined forces with Boryung to commercialize Vivozon's domestically developed non-narcotic painkiller, opiranserin (VVZ-149), in Korea.The partnership was formalized through a memorandum of understanding (MOU) signed on Wednesday, whic
Samsung Bioepis said it domestically released Epysqli (ingredient: eculizumab), a biosimilar referencing Soliris, at a much lower price than the original, on Monday. Soliris, developed by Alexion Pharmaceuticals and marketed by AstraZeneca, is used for treating rare conditions such as paroxysmal noc
A clue has been found to predict the onset of neurodegenerative diseases that have been a challenge in treating REM sleep behavior disorder.Korean researchers have developed a machine learning model to predict dementia and Parkinson's disease using the “brain waves” of REM sleep behavior disorder pa
AITRICS and Korea University Anam Hospital (KUAH) have signed a memorandum of understanding to advance medical AI technology.AITRICS is renowned for its expertise in biometric signal-based medical AI technology. Its flagship AI solution, AITRICS-VC, is designed to predict deteriorations in patient c
Kukje Pharma said Tuesday that it has signed a strategic marketing partnership contract with Celltrion for the domestic sales of Celltrion's CT-P42 (aflibercept), an Eylea biosimilar, for treating ophthalmic retinal diseases.Under the agreement, Celltrion will exclusively provide Kukje Pharma with d
Gencurix, NGeneBio's largest shareholder, has sold some of its shares to 10 people, including NGeneBio CEO Choi Dae-chul, drawing attention to its background.As a result of the stock transfer, the largest shareholder of NGeneBio has changed to KT, Korea's second-largest wireless carrier, which found
Coreline Soft said its artificial intelligence (AI)-powered coronary artery calcification automatic diagnostic solution, AVIEW CAC, has received 510(k) clearance from the U.S. FDA.A 510(k) is a premarket submission made to the FDA to demonstrate that the device to be marketed is as safe and effectiv
AbbVie Korea said the Korean health insurance coverage for Rinvoq (upadacitinib), a once-daily, oral, selective and reversible JAK1 inhibitor, has been expanded to treat moderately to severely active ulcerative colitis and Crohn's disease in adults, effective from April 1. Rinvoq is covered by healt
Influenza is an acute respiratory illness caused by a virus that can lead to complications in the respiratory system, including pneumonia, and major organ systems, including neurological complications, and in severe cases, death. It causes increased morbidity and mortality, especially in high-risk g
Yuyu Pharma said its urinary disorder treatment Yuhylyx Soft Capsule (dutasteride) has won approval from the food and drug administration of the Philippines and Myanmar and has completed product registration.These are expected to boost the company's exports to the Southeast Asian pharmaceutical mark
Pfizer Korea and Hanlim MS are strengthening their partnership to co-market immunology disease treatments.Pfizer Korea said Tuesday that the company has signed an agreement with Hanlim MS to co-market Enbrel (etanercept), the first anti-tumor necrosis factor (TNF)-α inhibitor approved for treating r